December 2006 Volume 2, Issue 12
Volume 2, Issue 12 | December 2006
December 2006
In this Issue
Genomics & Proteomics
Illumina, Solexa to merge
$600 million deal creates broad-based genetic analysis company.Applied Bio, Eagle to collaborate
Companies to co-develop detection device for protein and DNA analysis.Structure and function
NIH initiative seeks to speed up the process of determining protein structuresQ&A: William Radany, CEO, High Throughput Genomics
Radany discusses his plans for HTGInformatics
Raiders of the lost chemistry
Database to plumb depths of academic research.Gene Network Sciences receives SBIR
Company to continue development of its VisualHeart modeling software for predicting the cardiac effects of medications.Making a bid for grid
Altair and SciTegic team up to improve efficiencies in drug discovery work.Broadband engine speeds discovery
Mercury collaborates with Boston University to boost processing time.Automation & Instrumentation
Ambit, Cephalon sign screening agreement
Companies to tackle kinases, key molecules in many disease pathways.Waters, Advion to collaborate
Combination of ion mobility separation and chip-based sample introduction a win-winQ&A: Marc Casper, EVP, Thermo Fisher Scientific
Merger created a life sciences distribution, tools and reagents behemoth.Faster than a speeding toxicity
Iconix and Affymetrix pair up to improve speed of toxicogenomicsGamma Medica acquires AMI
Merger could mean the emergence of PET-MRI systems.Research & Development
Gene therapy for epilepsy
Researchers significantly reduce the development of epileptic seizures in rats.e-Therapeutics takes the road to Rio
Company forms discovery partnerships with two Brazilian groupsVistaGen, Sanwa collaborate on diabetes
Companies focus on use of stem cells.Applied NeuroSolutions inks deal with Eli Lilly
Companies to develop therapeutics to treat AD.Marcadia, IU in metabolic research deal
Deal gives the start-up company the rights to develop and market drug candidates.Editor's Focus
Peace: A nod to things pharma does right
As another year draws to a close, I find myself growing weary of the hell-fire and damnation—if only for one issue (so be warned). And so, my gentle readers, I have come to praise pharma, not to bury it.
Protein Therapy vs. Gene Therapy
Proteins are the most important molecules inside every living cell, tissue, organ—and inside the human body.Global News
Synthetic siRNA market shows significant growth potential
Growth rate of 9 percent is projected for the next year.Products released at LabAutomation 2007
Thermo Fisher, Qiagen, Xiril, Micronic, Corning, HamiltonNews Briefs
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
The unsung tools behind analytical testing success
Learn how fundamental laboratory tools like pipettes and balances support analytical precision.
Improving ALS research with pluripotent stem cell-derived models
Discover new advancements in modeling amyotrophic lateral sclerosis.
Automating 3D cell selection
Discover precise automated tools for organoid and spheroid handling.
